Jobs
-
Inhaler manufacturers who have been purchasing acrylonitrile butadiene styrene (ABS) for inhaler housings from either BASF or Ineos will now have a new supplier: Styrolution. Ineos’s Lustran, Novodur, and Absolac brands and BASF’s Terluran brand… Read more . . .
-
Swiss vaccine developer Mymetics Corporation has reclaimed an intranasal influenza vaccine that it had licensed to Solvay prior to Solvay’s acquisition by Abbott Laboratories. Solvay had conducted a Phase 1 trial that found the vaccine… Read more . . .
-
Job Title: DPI Analytical Senior Scientist Organization Unit: R&D – CMC – Strategic Product Enhancement The client, a global multinational company headquartered in Italy, is seeking an enthusiastic and self-motivated individual who would be interested… Read more . . .
-
Novartis Pharmaceuticals Canada has announced that the Québec provincial government will now provide reimbursement for the TOBI Podhaler tobramycin DPI for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis patients.The company cites data from… Read more . . .
-
Only about a month after entering the nasal delivery device market, Bespak has announced a second contract for development of an intranasal device. The company says that “a major global manufacturer of generic medicines” has… Read more . . .
-
Teva Respiratory has announced that it will provide assistance to patients affected by the impending phase out of the OTC Primatene Mist epinephrine inhaler. In addition to providing educational resources, the company says that it… Read more . . .
-
Submit proposals for short courses, roundtables, symposia, mini-symposia, and sunrise sessions at http://abstracts.aapspharmaceutica.com/aaps2012/login.asp by November 7, 2011. For any additional information, contact Bethany Daniel. Read more . . .
-
A Phase 1 clinical trial of a novel dry powder intranasal vaccine for prevention of the H5N1 influenza strain demonstrated that the product was well tolerated, and no serious adverse events occurred, according to developer… Read more . . .
-
The board of directors of contract research organization PPD has approved a $3.9 billion all cash deal which will take the company private after its acquisition by the Carlyle Group and Hellman & Friedman. PPD… Read more . . .
-
According to the British Pharmacopoeia website: “The British Pharmacopoeia Commission has recently endorsed the formation of a new Working Party for Inhaled Products (IP). The remit of the Working Party will be to review the… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK